23 September 2021 |

Raffles FO leads Hong Kong biotech firm Cellomics’ series B round

(from left): Cellomics co-founder and chairman, professor Michael Yang; RFO Group CEO and co­founder Kwan Chi Man; and Jacobson Pharma executive director Raymond Yim.
Text size
To access this content, please login or enquire for a free trial.To access this content, please click back to the home screen, then click “Menu” (bars in top left bars) and then “Login”.
To enquire for a free trial, please start here.
Need more help? Click here or email help@asianprivatebanker.com.

Last chance to register for Income Week 2021

Amidst continued pandemic recovery and heightened market volatility, there has never been a more opportune time for investors to arm themselves with income protection and growth ideas. Join us for Income Week to discuss the most interesting yield opportunities in cryptocurrencies, ESG and fixed income.

Register Now